2020/06/23 by S. Vincent Rajkumar · 1 citation
Economics, Econometrics and Finance · #Pharmaceutical Economics and Policy #Health Systems, Economic Evaluations, Quality of Life #Economic and Financial Impacts of Cancer
paper · pdf · doi:10.1038/s41408-020-0338-x
openalex publication_date 2020/06/23 · openalex created_date 2020/06/25 · openalex updated_date 2026/08/01
Global spending on prescription drugs in 2020 is expected to be ~1.3 trillion; the United States alone will spend ~350 billion 1 . These high spending rates are expected to increase at a rate of 3–6% annually worldwide. The magnitude of increase is even more alarming for cancer treatments that account for a large proportion of prescription drug costs. In 2018, global spending on cancer treatments was approximately 150 billion, and has increased by >10% in each of the past 5 years 2 .